Amanote Research
Register
Sign In
Correction: Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
Cancer immunology research
- United States
doi 10.1158/2326-6066.cir-15-0246
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Immunology
Date
October 6, 2015
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Requirements for Peptide-Induced T Cell Receptor Downregulation on Naive CD8+T Cells
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Intravaginal TLR Agonists Increase Local Vaccine-Specific CD8 T Cells and Human Papillomavirus-Associated Genital-Tumor Regression in Mice
Mucosal Immunology
Allergy
Immunology
CD8+ T Cell-Independent Tumor Regression Induced by Fc-Ox40l and Therapeutic Vaccination in a Mouse Model of Glioma
Journal of Immunology
Allergy
Immunology
GTL001, a Bivalent Therapeutic Vaccine Against Human Papillomavirus 16 and 18, Induces Antigen-Specific CD8+ T Cell Responses Leading to Tumor Regression
PLoS ONE
Multidisciplinary
Vaccination-Induced Functional Competence of Circulating Human Tumor-Specific CD8 T-Cells
International Journal of Cancer
Cancer Research
Oncology
CD8+ T Cells Modulate Autosomal Dominant Polycystic Kidney Disease Progression
Kidney International
Nephrology
Multiepitope CD8+ T Cell Response to a NY-ESO-1 Peptide Vaccine Results in Imprecise Tumor Targeting
Journal of Clinical Investigation
Medicine
CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain
Journal of Neuroscience
Neuroscience
Nondominant CD8 T Cells Are Active Players in the Vaccine-Induced Antitumor Immune Response
Journal of Immunology
Allergy
Immunology
